TapewireFind a company

person · Reporting owner

Okupe Oluyemi

Disclosed activity across 1 company

Tapewire entity
21133
SEC CIK
0001907056

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Chief Financial OfficerOctober 01, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date October 01, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect234,527 Reported balance After 2026-10-01 transaction · row 1
1 source row

Row 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 51,671 $33.14 $1,712,376.94
Disclosure

SEC source: 0001773751-25-000100 · wk-form4_1742337309.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,366

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 22:35 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 93,718 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-25-000100 · wk-form4_1742337309.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,037

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 21:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 2,530 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-25-000081 · wk-form4_1741296715.xml · derivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,770

Underlying: Class A Common Stock · 2,530 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 21:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 2,530 $5.01 $12,675.30
Disclosure

SEC source: 0001773751-25-000081 · wk-form4_1741296715.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,319

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:42 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 GrantRestricted Stock Unit · Derivative 183,719 $0.00 $0.00
Disclosure

SEC source: 0001773751-25-000076 · wk-form4_1741210940.xml · derivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,719

Underlying: Class A Common Stock · 183,719 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 21:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,437 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 413,300

Underlying: Class A Common Stock · 6,437 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 21:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $43.23 $43,103.70
Disclosure

SEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,789

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.18 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 21:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $43.21 $60,098.57
Disclosure

SEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,786

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.12 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 21:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $42.96 $394,898.19
Disclosure

SEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,177

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $42.59 - $43.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 10, 2025 Filed Feb 11, 2025 21:16 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,437 $5.01 $32,249.37
Disclosure

SEC source: 0001773751-25-000039 · wk-form4_1739308580.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,437 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 419,737

Underlying: Class A Common Stock · 6,437 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F6 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $39.30 $39,186.89
Disclosure

SEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,933

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $39.25 - $39.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $39.23 $54,573.94
Disclosure

SEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,930

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $39.17 - $39.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,913 $39.20 $74,992.28
Disclosure

SEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,321

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $39.00 - $39.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,280 $38.73 $281,976.97
Disclosure

SEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,234

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $38.40 - $38.96. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 04, 2025 Filed Feb 5, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,437 $5.01 $32,249.37
Disclosure

SEC source: 0001773751-25-000036 · wk-form4_1738791087.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,437 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 426,174

Underlying: Class A Common Stock · 6,437 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $24.57 $24,495.09
Disclosure

SEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,077

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.47 - $24.675. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $24.54 $34,140.15
Disclosure

SEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,074

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.46 - $24.69. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $24.42 $224,448.01
Disclosure

SEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,465

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.21 - $24.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 13, 2025 Filed Jan 14, 2025 21:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,437 $5.01 $32,249.37
Disclosure

SEC source: 0001773751-25-000010 · wk-form4_1736890295.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 6,437 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 432,611

Underlying: Class A Common Stock · 6,437 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $24.66 $24,589.21
Disclosure

SEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,221

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.63 - $24.81. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $24.71 $34,373.70
Disclosure

SEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,218

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.61 - $24.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $24.67 $226,820.73
Disclosure

SEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,609

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.30 - $25.065. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 6,437 $5.01 $32,249.37
Disclosure

SEC source: 0001773751-25-000004 · wk-form4_1736199598.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
December 26, 2024 Filed Dec 27, 2024 21:48 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 4,213 $29.98 $126,317.96
Disclosure

SEC source: 0001773751-24-000411 · wk-form4_1735336073.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,365

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 20, 2024 Filed Dec 23, 2024 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 4,213 $25.75 $108,489.38
Disclosure

SEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,578

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.64 - $25.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 20, 2024 Filed Dec 23, 2024 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 4,213 $25.75 $108,497.39
Disclosure

SEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,791

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.645 - $25.92. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 20, 2024 Filed Dec 23, 2024 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 6,320 $25.80 $163,047.15
Disclosure

SEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,004

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.68 - $25.955. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 20, 2024 Filed Dec 23, 2024 21:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 4,213 $25.75 $108,496.97
Disclosure

SEC source: 0001773751-24-000406 · wk-form4_1734990031.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,324

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.65 - $25.875. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 00:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 22,988 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · derivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,845

Underlying: Class A Common Stock · 22,988 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 00:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,334 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · derivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,010

Underlying: Class A Common Stock · 18,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 00:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 52,396 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · derivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,976

Underlying: Class A Common Stock · 52,396 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").

Read SEC document
December 13, 2024 Filed Dec 18, 2024 00:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 51,573 $30.02 $1,548,221.46
Disclosure

SEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,537

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
December 13, 2024 Filed Dec 18, 2024 00:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 93,718 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-24-000396 · wk-form4_1734480121.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 23:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 97,776 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · derivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 439,048

Underlying: Class A Common Stock · 97,776 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F6 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 23:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 90,412 $30.01 $2,713,010.97
Disclosure

SEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,392

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F5 · balance_after: Includes 1,423 shares acquired on November 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 23:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $26.65 $245,016.43
Disclosure

SEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,381

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.52 - $26.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 23:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $26.58 $26,498.57
Disclosure

SEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 207,574

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.52 - $26.62. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 23:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $26.58 $36,970.14
Disclosure

SEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 208,571

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.52 - $26.62. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 23:32 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 97,776 $5.01 $489,857.76
Disclosure

SEC source: 0001773751-24-000376 · wk-form4_1732663958.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 209,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 83,209 $0.00 Strike: $5.01 $0.00
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · derivative · entry 8

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 536,824

Underlying: Class A Common Stock · 83,209 shares

Expires 2032-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F7 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 26,100 $0.00 Strike: $11.53 $0.00
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · derivative · entry 7

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,732

Underlying: Class A Common Stock · 26,100 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F6 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 131,305 $30.06 $3,947,067.69
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 6

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,186

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 9,193 $28.38 $260,915.73
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 5

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 243,491

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.10 - $28.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,391 $28.72 $39,954.11
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 4

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 252,684

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.16 - $28.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 997 $28.76 $28,671.23
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 3

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 254,075

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.74 - $28.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 83,209 $5.01 $416,877.09
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 2

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 255,072

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document
November 13, 2024 Filed Nov 14, 2024 21:57 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 26,100 $11.53 $300,933.00
Disclosure

SEC source: 0001773751-24-000357 · wk-form4_1731621448.xml · nonDerivative · entry 1

Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.